From: The clinical use of biomarkers as prognostic factors in Ewing sarcoma
Author | Year | Pt number | P |
---|---|---|---|
Delepine et al, J Chemother 9 (5), 352-63[49] | 1997 | 39 | 0.05 |
Picci et al, J Clin Oncol 15 (4), 1553-9[50] | 1997 | 118 | 0.0001 |
Aparicio et al, Oncology 55, 20-6[9] | 1998 | 116 | 0.018 |
Paulussen et al, J Clin Oncol 16 (9), 3044-52[39] | 1998 | 114 | S |
Abudu et al, J Bone Joint Surg 81 (2), 317-22[51] | 1999 | 50 | 0.03 |
Ahrens et al, Med Pediatr Oncol 32, 186-95[10] | 1999 | 177 | 0.27 |
Baldini et al, Ann Surg 230 (1), 79-86[40] | 1999 | 37 | 0.01 |
Bacci et al, J Clin Oncol 18, 4-11[13] | 2000 | 359 | 0.001 |
De Alava et al, Cancer 89, 783-92[25] | 2000 | 55 | 0.001 |
Ohali et al, J Clin Oncol 21, 3836-43[52] | 2003 | 31 | 0.0001 |
Scotlandi et al, Eur J Cancer 41, 1349-61[53] | 2005 | 113 | 0.05 |
Bacci et al, Acta Oncol 45, 469-75[16] | 2006 | 579 | 0.0005 |
Mikulic et al, J Pediatr Surg 41, 524-9[31] | 2006 | 27 | 0.047 |
Avigad et al, Clin Cancer Res 13 (19), 5777-83[54] | 2007 | 32 | 0.13 |
Yonemori, J Cancer Res Clin Oncol 134, 389-95v [34] | 2008 | 79 | 0.04 |
Meynet et al, Cancer Res 70 (9), 3730-8[55] | 2010 | 97 | 0.02 |